Home › Upcoming votes › Actinium Pharmaceuticals, Inc.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Actinium Pharmaceuticals, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | ELECTION OF DIRECTORS Director election |
Board | For | 2 nominees; support 80% to 84% |
| 2 | RATIFICATION OF THE APPOINTMENT OF CBIZ CPAs P.C | Board | For | — |
| 3 | Advisory Vote on the Compensation of our Named Executive Officers Say on pay |
Board | For | 74% support |
From Actinium Pharmaceuticals, Inc.’s Form 8-K, filed November 26, 2025, for the meeting held November 26, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Ajit S. Shetty | 80% | — |
| Elect Director: June S. Almenoff | 84% | — |
| 2. To ratify the appointment of CBIZ as the Company's independent registered public accounting firm for the fiscal year ending December 31, | 90% | — |
| 3. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers | 74% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.